Still on the same topic, a paper by van de Cauter and coworkers investigated the relationship of RTW, psychosocial wellbeing and HRQoL in coronary artery disease patients. Based on data of the EUROASPIRE IV survey population, the authors performed a secondary data analysis to investigate RTW and several characteristics at the time of the coronary event and, secondly, the relation of RTW to psychosocial wellbeing and HRQoL. The authors found that 76% of the included patients returned to work in the period of 6 months to 3 years after discharge. RTW was negatively associated with psychosocial wellbeing (depression, anxiety) and positively associated with HRQoL, whereby patients who resumed their work reported fewer symptoms of anxiety/depression and better HeartQoL scores. 6 In consideration of a growing aging population accompanied by a longer working age, future research should pay attention to a thorough follow-up of mental health and HRQoL at different stages of treatment and during RTW, and to rehabilitation programmes including relevant work characteristics.
Atrial fibrillation and myocardial infarction
This combination is not uncommon. Coronary heart disease is a common comorbidity in patients with atrial fibrillation, and atrial fibrillation is also one of the most common complications of acute myocardial infarction (MI), with a prevalence ranging between 5% and 18%. 7 In MI patients the occurrence of atrial fibrillation reaches 21%, and atrial fibrillation is related to an increased risk of MI, especially in patients with no history of coronary artery disease. 8, 9 Here is presented a large observational nationwide study of patients with acute MI admitted to hospitals in Norway from 2013 to 2016, where, in keeping with the literature, the total prevalence of atrial fibrillation was high (16.1%). Patients with atrial fibrillation had an increased risk of stroke and/or death during the longterm follow-up compared with those without atrial fibrillation. However, the interesting finding was the poorly implemented guideline recommendation for medical treatment. In fact, only 56.3% of the patients with a CHA2DS2-VASc risk score of 2 or greater were discharged with anticoagulant therapy. Thus many patients with MI and atrial fibrillation are probably undertreated with respect to stroke prevention. This study highlights an area with potential for improvement in the treatment of acute MI.
Heart failure in the elderly
Despite the stable incidence of heart failure (HF) over previous decades, its prevalence is growing, mostly because of the aging population and improved survival as a result of progress in CVD/HF management. 10 This important issue is addressed by the analysis of the CHECK-HF registry (Chronisch Hartfalen ESCrichtlijn Cardiologische praktijk Kwaliteitsproject HartFalen) presented in the current issue. This analysis compiled data on 8351 patients with chronic HF and reduced ejection fraction (HFrEF) older than 60 years from 34 Dutch outpatient clinics, treated between 2013 and 2016. The study showed that the aging of patients with chronic HFrEF was associated with more comorbidities, including a greater likelihood of worsening renal function, atrial fibrillation, type 2 diabetes, hypertension, thyroid disorders and chronic obstructive pulmonary disease (as previously described). 11 However, the elderly less frequently received optimal medical therapy for HF (e.g. beta-blockers, renin-angiotensin system inhibitors, mineralocorticoid receptor antagonists and ivabradine), but were significantly more often treated with diuretics compared with younger patients. The contraindication or intolerance rates were significantly higher for all drugs among the elderly, but in approximately 60% of patients the reasons for underprescription remained unspecified. Furthermore, as patients got older, the uptitration of drugs to target doses was less likely. Frailty in elderly patients is highly prevalent and is associated with a worse prognosis and might explain in some part the lower prescription rate in elderly patients here observed. 12 What is a healthy diet?
To address this question, a systematic review and metaanalysis of the risk associated with each component of diet within its food group is here presented. A total of 3011 studies was reviewed, checking for heterogeneity and the potential for confounding, the risk of bias, when available. With such a rigorous method, only 16 reviews for all-cause mortality and 17 reviews for CVD were included at the end, showing the limited evidence on this matter. The results suggest that many dietary components appear to be beneficial for CVD and mortality, including grains, fish, nuts and vegetables. Within the fruit and vegetables category many foods presumed to be beneficial actually have insufficient evidence to suggest benefit in CVD, but there is modest evidence for benefit for raw vegetables, root vegetables, green leafy vegetables, cooked vegetables and cruciferous vegetables and all-cause mortality. Foods that appear harmful include processed meat and tinned fruit for all-cause mortality and processed meat and red meat for CVD. The review provides a comprehensive summary of the evidence of benefit or harm of food items that may help physicians counsel their patients better about dietary advice. The main findings are in keeping with the evidence that the Mediterranean diet, combined with an active lifestyle, has a synergistic inverse association with CVD, i.e. the perfect recipe for immortality. 13, 14 Mitral valve surgery: does gender matter?
In a large database from the clinical trial unit of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital, the difference in mitral valve management between men and women was retrospectively evaluated. In particular, in individuals undergoing mitral valve surgery, the general disease characteristics, treatment and outcome were studied. A significant difference between men and women in the type of surgery (more frequently mitral valve replacement and concomitant atrial fibrillation ablation and tricuspid valve repair in women) and in perioperative complications and mortality (more frequent in women) was observed. Baseline characteristics were also significantly different, with women being older, more symptomatic and presenting more frequently with comorbidities and rheumatic valve disease. This is in line with other studies showing that women are often undertreated 15, 16 or referred to surgery at a very late stage. Thus the take-home message for referring physicians and treating cardiologists is to perform in women a careful and customised risk stratification 17 and close follow-up, with possible early referral for mitral valve surgical treatment in order to avoid the higher peri and postoperative complications and mortality currently observed as compared with men. The already ongoing large national and international awareness campaigns will, hopefully, help identify the genuine differences between men and women. 18 Cardiovascular screening in young soccer players Electrocardiographic 19 and echocardiographic 20 interpretation among athletes, particularly in pre-puberty, has been raising increasing interest. The prevalence of cardiac abnormalities in a large population of consecutive young male soccer players undergoing preparticipation screening through electrocardiogram and transthoracic echocardiography was evaluated in 2261 athletes aged 12.4 years. Training-unrelated electrocardiogram abnormalities were observed in 2.9% of athletes, while abnormal transthoracic echocardiography was observed in 4.5% of athletes. In the authors' opinion ECG proved to be a powerful indicator of cardiomyopathies. However, some limitation should be acknowledged, such as the cross-sectional design of the study or how the authors are convinced that all pathological conditions were correctly identified. Moreover, the authors declare that due to the lack of clinical and echocardiographic follow-up data, no conclusion can be derived concerning the cost-effectiveness of such an intervention in terms of long-term clinical benefit.
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